Literature DB >> 18650640

Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.

Andrew J Spillane1, Robyn P M Saw, Monica Tucker, Karen Byth, John F Thompson.   

Abstract

OBJECTIVE: This study aims to objectively define the criteria for assessing the presence of lymphedema and to report the prevalence of lymphedema after inguinal and ilio-inguinal (inguinal and pelvic) lymph node dissection for metastatic melanoma. SUMMARY BACKGROUND DATA: Lymphedema of the lower limb is a common problem after inguinal and ilio-inguinal dissection for melanoma. The problem is variably perceived by both patients and clinicians. Adding to the confusion is a lack of a clear definition or criteria that allow a diagnosis of lymphedema to be made using the various subjective and objective diagnostic techniques available.
METHODS: Lymphedema was assessed in 66 patients who had undergone inguinal or ilio-inguinal dissection. Nine patients received postoperative radiotherapy. Assessment was performed by limb circumference measurements at standardized intervals, volume displacement measurements, and volumetric assessment calculated using an infrared optoelectronic perometer technique. Comparisons were made with the contralateral untreated limb. Patient assessment of the severity of lymphedema was compared with objective measures of volume discrepancy. Classification and regression tree analysis was used to determine a threshold fractional leg volume or circumference increase above which patients could self-detect volume changes that they reliably considered to indicate lymphedema.
RESULTS: Based on classification and regression tree analysis, both the whole limb perometer volume percentage change > or = 15% and the sum of circumferences (of 6 defined sites along the limb) percentage change > or = 7% performed well overall in predicting moderate or severe perceived swelling (defined as "lymphedema"). Both definitions predicted lymphedema in approximately the same fraction of patients with misclassification rates of 16% and 15%, sensitivity 56% and 50%, specificity 95% and 100%, respectively. Using > or = 15% of whole perometer volume percentage change, 12% of patients with inguinal dissection had lymphedema compared with 23% of patients with ilio-inguinal dissection. Combining both groups, 18% of patients had lymphedema, positive and negative predictive values 82% and 84%. Using the definition > or = 7% of the sum of circumferences percent change, 7% of patients with inguinal dissection had lymphedema compared with 19% of patients with ilio-inguinal dissection (overall 14% had lymphedema, positive and negative predictive values 100% and 82%, respectively). Of the variables assessed, only radiotherapy was significantly associated with predicted lymphedema (OR 12.6; 95% CI 1.7 to > 100; P = 0.001 using whole perometer change > or = 15%; and OR 13.0; 95%CI 1.4 to > 100; P = 0.021 using sum circumference change > or = 7%).
CONCLUSIONS: A whole limb perometer volume percentage change of > or = 15% and increase in the sum of circumferences of the defined points along the limb > or = 7% provide robust definitions of lower limb lymphedema.

Entities:  

Mesh:

Year:  2008        PMID: 18650640     DOI: 10.1097/SLA.0b013e31817ed7c3

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  Physical activity and lower limb lymphedema among uterine cancer survivors.

Authors:  Justin C Brown; Gabriella M John; Saya Segal; Christina S Chu; Kathryn H Schmitz
Journal:  Med Sci Sports Exerc       Date:  2013-11       Impact factor: 5.411

2.  Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.

Authors:  James W Jakub; Alicia M Terando; Amod Sarnaik; Charlotte E Ariyan; Mark B Faries; Sabino Zani; Heather B Neuman; Nabil Wasif; Jeffrey M Farma; Bruce J Averbook; Karl Y Bilimoria; Travis E Grotz; Jacob B Jake Allred; Vera J Suman; Mary Sue Brady; Douglas Tyler; Jeffrey D Wayne; Heidi Nelson
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

Review 3.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

4.  Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.

Authors:  John R Hyngstrom; Yi-Ju Chiang; Kate D Cromwell; Merrick I Ross; Yan Xing; Kristi S Mungovan; Jeffrey E Lee; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jane M Armer; Janice N Cormier
Journal:  Melanoma Res       Date:  2013-08       Impact factor: 3.599

5.  Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.

Authors:  A P T van der Ploeg; A C J van Akkooi; P I M Schmitz; A N van Geel; J H de Wilt; A M M Eggermont; C Verhoef
Journal:  Ann Surg Oncol       Date:  2011-05-03       Impact factor: 5.344

6.  Saphenous vein sparing superficial inguinal dissection in lower extremity melanoma.

Authors:  Muhammed Beşir Oztürk; Arzu Akan; Ozay Ozkaya; Onur Egemen; Ali Rıza Oreroğlu; Turgut Kayadibi; Mithat Akan
Journal:  J Skin Cancer       Date:  2014-07-13

7.  Lymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging.

Authors:  Melissa B Aldrich; Renie Guilliod; Caroline E Fife; Erik A Maus; Latisha Smith; John C Rasmussen; Eva M Sevick-Muraca
Journal:  Biomed Opt Express       Date:  2012-05-03       Impact factor: 3.732

8.  Long-term treatment outcome after only popliteal lymph node dissection for nodal metastasis in malignant melanoma of the heel: the only "interval node" dissection can be an adequate surgical treatment.

Authors:  Kentaro Tanaka; Hiroki Mori; Mutsumi Okazaki; Aya Nishizawa; Hiroo Yokozeki
Journal:  Case Rep Oncol Med       Date:  2013-05-12

9.  Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients.

Authors:  David Cibula; Martina Borčinová; Simone Marnitz; Jiří Jarkovský; Jaroslav Klát; Radovan Pilka; Aureli Torné; Ignacio Zapardiel; Almerinda Petiz; Laura Lay; Borek Sehnal; Jordi Ponce; Michal Felsinger; Octavio Arencibia-Sánchez; Peter Kaščák; Kamil Zalewski; Jiri Presl; Alicia Palop-Moscardó; Solveig Tingulstad; Ignace Vergote; Mikuláš Redecha; Filip Frühauf; Christhardt Köhler; Roman Kocián
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

10.  Prevention of Secondary Lymphedema after Complete Lymph Node Dissection in Melanoma Patients: The Role of Preventive Multiple Lymphatic-Venous Anastomosis in Observational Era.

Authors:  Eleonora Nacchiero; Michele Maruccia; Fabio Robusto; Rossella Elia; Alessio Di Cosmo; Giuseppe Giudice
Journal:  Medicina (Kaunas)       Date:  2022-01-13       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.